gsk presentation, page-8

re: amex, inhaler look amex I tend to agree with you but I have never seen the relenza inhaler device. As you say they are probably using it as an excuse. I think however they may look at ways of increasing effective supply (by making a longer course pack or an iv version) without commiting too much extra in production facilities which will become obsolete once LANI starts to be produced.